why the drop, page-3

Hi folks

PSX has basically been a ten bagger situation for starters since its lows around 4 cents a couple of years ago.

The company 'appears' to be on the right track.

There has been a lot of hype re this Canon deal. I see this as only one of the potential winners in the developing PSX portfolio. I personally would rate Sorafin (psoriasis) every bit as important as the Canon deal and in fact was the reason this company went well over $1.00 before it all went so horribly, and unprofessionally wrong for the company due to incompetence by former management and an inability to carry out simple toxicity tests (synergy between the two major compounds in sorafin) that would have dramatically changed the companys future....and many shareholders as well.

I do not hold this currently, however do see some promise there.

Seems they are going all out for a portfolio approach these days.

Will be interesting to see what the company does re their ALT Analytica holding.

I seem to be getting some deja vu re SEN Senetas and Kusp spin off.........................